Skip to main content

Archived Comments for: CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer

Back to article

  1. Additional data for this article

    Claire Hansford, BioMed Central

    13 November 2008

    Due to a technical fault the additional file links have become unavailable for this article.

    They are now available from:

    Additional file 1:


    Additional file 2:


    Additional file 3:


    Competing interests

    None declared